Medical Devices

InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors

Retrieved on: 
Friday, September 23, 2022

Scott Shuda, Chairman of InfuSystems Board of Directors, said, We are pleased to welcome Rimmy as a new independent director on InfuSystems Board.

Key Points: 
  • Scott Shuda, Chairman of InfuSystems Board of Directors, said, We are pleased to welcome Rimmy as a new independent director on InfuSystems Board.
  • Rimmy first invested in the Company in 2012, and has an earned reputation as a particularly attentive shareholder.
  • I have long admired InfuSystem, and believe the Company has opportunity to significantly expand its business to the benefit of all stakeholders, said Mr. Malhotra.
  • Since November 2019, Mr. Malhotra has been a member of the Board of Directors of Optex Systems Holdings, Inc., an optical systems manufacturer, and also sits on the board of Scotts Liquid Gold.

The Worldwide Kidney Stone Retrieval Devices Industry is Expected to Reach $3.6 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

Kidney stone retrieval devices are used in minimally invasive or non-invasive treatment options for the removal of kidney stones.

Key Points: 
  • Kidney stone retrieval devices are used in minimally invasive or non-invasive treatment options for the removal of kidney stones.
  • Considerably smaller ureter scopes, quartz fibers, and lithotripter probes have made the extraction of kidney stones from previously unreachable locations far safer than traditional surgical options.
  • For instance, the Dretler stone cone is one innovation that inhibits stone migration during the treatment.
  • The demand for kidney stone retrieval devices was uneven, with installation delays and a decline in manufacturing during the pandemic.

Optical Devices for Monitoring Patient Glucose Levels - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

The "Optical Devices for Monitoring Patient Glucose Levels" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Optical Devices for Monitoring Patient Glucose Levels" report has been added to ResearchAndMarkets.com's offering.
  • Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing.
  • Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing.
  • What will be the impact of economic, technology, and regulatory factors on the commercial potential of optical device patient monitors?

Global Clinical Trial Imaging Market Report 2022: Industry to Grow at 9.47% Annually Through 2029 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

The "Clinical Trial Imaging Market Analysis by Product and Service, by Modality, by Therapeutic Area, End user and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Clinical Trial Imaging Market Analysis by Product and Service, by Modality, by Therapeutic Area, End user and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The clinical trial imaging market size is estimated to be USD 1.8 billion in 2021 and is expected to witness a CAGR of 9.47% during the forecast period 2022-2029.
  • The rising number of CROs, escalating R&D spending, growing pharmaceutical and biotechnology industries are some of the key drivers for the market growth.
  • Segmentation: Clinical Trial Imaging Market Report 2021-2029 Product & Service (Revenue, USD Billion)

United Kingdom National Institute for Health and Care Excellence (NICE) Publishes Interventional Procedure Guidance (IPG) for ReActiv8® Restorative Neurostimulation™

Retrieved on: 
Friday, September 23, 2022

ReActiv8 is currently the only technology offering restorative neurostimulation to the NHS for refractory mechanical chronic low back pain (CLBP).

Key Points: 
  • ReActiv8 is currently the only technology offering restorative neurostimulation to the NHS for refractory mechanical chronic low back pain (CLBP).
  • This new guidance will enable patients to have greater access to the therapy when previous treatment options have not proven successful.
  • This new guidance will allow more patients to gain access to ReActiv8 within the U.K. and further afield.
  • Mainstay Medical is a medical device company focused on commercializing its innovative implantable Restorative Neurostimulation system, ReActiv8, for people with disabling mechanical CLBP.

Global Radiofrequency-Based Devices Market Report 2022: Featuring Abbott, Becton Dickinson, Johnson & Johnson & Others - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

Geographically, the following regions together with the listed national/local markets are fully investigated:

Key Points: 
  • Geographically, the following regions together with the listed national/local markets are fully investigated:
    Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
    APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

The Worldwide Pulse Oximeters Industry is Expected to Reach $3.9 Billion by 2031 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

In addition, surge in geriatric population and rise in chronic health conditions including COP and sleep apnea, have fueled the growth of pulse oximeters market.

Key Points: 
  • In addition, surge in geriatric population and rise in chronic health conditions including COP and sleep apnea, have fueled the growth of pulse oximeters market.
  • In addition, increase in prevalence of diseases such as hypertension, asthma, diabetes, and cardiac arrhythmia has significantly uplifted the demand for pulse oximeters.
  • Fingertip pulse oximeters are one such portable oximeters used in all healthcare settings including homecare, clinical settings, and hospitals.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pulse oximeters market analysis from 2021 to 2031 to identify the prevailing pulse oximeters market opportunities.

The Worldwide Next Generation Diabetes Therapy and Drug Delivery Industry is Expected to Reach $28 Million by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

The global next generation diabetes therapy and drug delivery market is segmented based on product, demographic, indication, end user, and region.

Key Points: 
  • The global next generation diabetes therapy and drug delivery market is segmented based on product, demographic, indication, end user, and region.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the next generation diabetes therapy and drug delivery market analysis from 2020 to 2030 to identify the prevailing next generation diabetes therapy and drug delivery market opportunities.
  • In-depth analysis of the next generation diabetes therapy and drug delivery market segmentation assists to determine the prevailing market opportunities.
  • The report includes the analysis of the regional as well as global next generation diabetes therapy and drug delivery market trends, key players, market segments, application areas, and market growth strategies.

Global Nephrotic Syndrome Diagnostics & Therapeutics Market 2022: Featuring Abbott, AstraZeneca, Eli Lilly, GlaxoSmithKline & More - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

The "Global Nephrotic Syndrome Diagnostics & Therapeutics Market Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Nephrotic Syndrome Diagnostics & Therapeutics Market Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global nephrotic syndrome diagnostics & therapeutics market is anticipated to grow at a CAGR of 5.6% during the forecast period.
  • Nephrotic syndrome is a kidney disease in which the body excretes an excessive amount of protein in the urine.
  • Moreover, pipeline drugs for nephrotic syndrome would drive the demand creating opportunities for the growth of the market.

Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients

Retrieved on: 
Friday, September 23, 2022

Leuko, an MIT startup developing PointCheckTM, the first solution that enables at-home noninvasive white blood cell (WBC) monitoring, today announced a first closing of $5 million for their Series A round.

Key Points: 
  • Leuko, an MIT startup developing PointCheckTM, the first solution that enables at-home noninvasive white blood cell (WBC) monitoring, today announced a first closing of $5 million for their Series A round.
  • Leuko will also continue to pursue its go-to-market and partnership activities with healthcare providers, medical device distributors and pharmaceutical companies.
  • Low WBC levels is one of the most common as well as most devastating and costliest side effects of cancer chemotherapy.
  • With Leuko, patients simply place their finger onto an internet connected PointCheckTM device for just 1 minute a day.